The newly released 2009 edition of Thomson Reuters’ Journal Citation Report
includes official Impact Factors for 77 BioMed Central journals, 54 of which
are new or improved.
- Genome Biology (IF 6.63)
increased its Impact Factor and remains BioMed Central’s most highly cited
- BMC Biology
(IF 5.64) is now ranked #4 of 73 in the BIOLOGY category.
- BMC Medicine
(IF 3.99) climbs to #18 of 132 in MEDICINE, GENERAL &
- Five more medical journals in the BMC series received their first Impact
- BMC Plant Biology
(IF 3.77) remains in the top 10% of the PLANT SCIENCES
category, while Plant Methods
(IF 2.98) joins the category in the top 15%.
- Biotechnology for
Biofuels (IF 4.12) received an impressive first Impact Factor.
- Breast Cancer Research
(IF 5.33) has overtaken its closed-access rival to become the highest ranked
breast cancer journal.
- Malaria Journal increased
its Impact Factor to 3.00, maintaining its position at #2 in the TROPICAL
- Orphanet Journal of Rare Diseases
(IF 5.84) experienced a significant gain, taking it to #7 of 92 in the
MEDICINE, RESEARCH & EXPERIMENTAL category.
- Parasites & Vectors
(IF 2.05) made its debut in the JCR, ranked #11 of 28 in the PARASITOLOGY
- Acta Veterinaria Scandinavica
(IF 1.00) saw an increased Impact Factor for the 3rd successive year.
- Journal of Neuroinflammation
(IF 4.68) and Molecular
Neurodegeneration (IF 5.09) both appeared in the top 20% of titles in
the NEUROSCIENCES category.
Full Impact Factor listing (new or increased Impact Factors
are shown in bold)